{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T14:59:01Z","timestamp":1649170741454},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med.","J. Jpn. Soc. Intern. Med"],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/naika.102.1098","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T23:12:41Z","timestamp":1399677161000},"page":"1098-1104","source":"Crossref","is-referenced-by-count":0,"title":["4. Nephrotic Syndrome"],"prefix":"10.2169","volume":"102","author":[{"given":"Shoichi","family":"Maruyama","sequence":"first","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1"},{"key":"2","unstructured":"2) Segarra-Medrano A, et al: Biological markers of nephrotic syndrome: a few steps forward in the long way. Nefrologia 32:558-572, 2012. doi: 10.3265\/Nefrologia.pre2012.Jun.11396"},{"key":"3"},{"key":"4","unstructured":"4) Garin EH, et al:Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int 78:296-302, 2010. doi: 10.1038\/ki.2010.143ki2010143 [pii]."},{"key":"5","unstructured":"5) Garin EH, et al:Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol 20:260-266, 2009. doi: 10.1681\/ASN.2007080836ASN.2007080836 [pii]."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Bakker WW, et al:Altered activity of plasma hemopexin in patients with minimal change disease in relapse. Pediatr Nephrol 20: 1410-1415, 2005. doi: 10.1007\/s00467-005-1936-3.","DOI":"10.1007\/s00467-005-1936-3"},{"key":"7"},{"key":"8","unstructured":"8) Wei C, et al: Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17: 952-960, 2011. doi: 10.1038\/nm.2411nm.2411[pii]."},{"key":"9","unstructured":"9) Wei C, et al: Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol 23: 2051-2059, 2012. doi: 10.1681\/ASN.2012030302ASN.2012030302[pii]."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Beck LH Jr, et al: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. The New England journal of medicine 361: 11-21, 2009.","DOI":"10.1056\/NEJMoa0810457"},{"key":"11"},{"key":"12"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Hofstra JM, et al: Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 23: 1735-1743, 2012. doi: ASN.2012030242 [pii] 10.1681\/ASN.2012030242.","DOI":"10.1681\/ASN.2012030242"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Bruschi M, et al: Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens: J Proteomics 74: 2008-2017, 2011. doi: 10.1016\/j.jprot.2011.05.021 S1874-3919 (11) 00212-0 [pii].","DOI":"10.1016\/j.jprot.2011.05.021"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Wakui H, et al: Circulating antibodies against alpha-enolase in patients with primary membranous nephropathy (MN). Clin Exp Immunol 118: 445-450, 1999. doi: cei1080 [pii].","DOI":"10.1046\/j.1365-2249.1999.01080.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Murtas C, et al:Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin J Am Soc Nephrol 7:1394-1400, 2012. doi: CJN.02170312 [pii] 10.2215\/CJN.02170312.","DOI":"10.2215\/CJN.02170312"},{"key":"17"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/102\/5\/102_1098\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T16:57:35Z","timestamp":1621443455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/102\/5\/102_1098\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.102.1098","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}